ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Biotecnol Limited

Biotecnol Limited is an active company incorporated on 18 September 2013 with the registered office located in London, City of London. Biotecnol Limited was registered 11 years ago.
Status
Active
Active since incorporation
Company No
08696340
Private limited company
Age
11 years
Incorporated 18 September 2013
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 18 September 2024 (11 months ago)
Next confirmation dated 18 September 2025
Due by 2 October 2025 (24 days remaining)
Last change occurred 4 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
6th Floor One London Wall
London
EC2Y 5EB
England
Address changed on 21 Jul 2023 (2 years 1 month ago)
Previous address was 2 Temple Back East Temple Quay Bristol BS1 6EG England
Telephone
02081443466
Email
Unreported
People
Officers
1
Shareholders
26
Controllers (PSC)
1
Director • PSC • Ceo Biotecnology Company • Portuguese • Lives in Portugal • Born in Oct 1967
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Brands
Biotecnol
Biotecnol is a private biopharmaceutical company specializing in immuno-oncology, developing antibody-based immunotherapies that activate and direct the patient's immune system to combat various cancers.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£21.85K
Decreased by £3.3K (-13%)
Turnover
Unreported
Same as previous period
Employees
1
Same as previous period
Total Assets
£21.85K
Decreased by £3.39K (-13%)
Total Liabilities
-£910
Increased by £40 (+5%)
Net Assets
£20.94K
Decreased by £3.43K (-14%)
Debt Ratio (%)
4%
Increased by 0.72% (+21%)
Latest Activity
Full Accounts Submitted
5 Months Ago on 31 Mar 2025
Confirmation Submitted
11 Months Ago on 30 Sep 2024
Full Accounts Submitted
1 Year 4 Months Ago on 2 May 2024
Dr Pedro Maria Do Carmo De Noronha Pissarra (PSC) Details Changed
1 Year 4 Months Ago on 15 Apr 2024
Dr Pedro Maria Do Carmo De Noronha Pissarra Details Changed
1 Year 4 Months Ago on 15 Apr 2024
Confirmation Submitted
1 Year 11 Months Ago on 28 Sep 2023
Inspection Address Changed
2 Years 1 Month Ago on 21 Jul 2023
Registers Moved To Inspection Address
2 Years 1 Month Ago on 20 Jul 2023
Full Accounts Submitted
2 Years 5 Months Ago on 28 Mar 2023
Confirmation Submitted
2 Years 11 Months Ago on 28 Sep 2022
Get Credit Report
Discover Biotecnol Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 31 Mar 2025
Confirmation statement made on 18 September 2024 with no updates
Submitted on 30 Sep 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 2 May 2024
Director's details changed for Dr Pedro Maria Do Carmo De Noronha Pissarra on 15 April 2024
Submitted on 16 Apr 2024
Change of details for Dr Pedro Maria Do Carmo De Noronha Pissarra as a person with significant control on 15 April 2024
Submitted on 16 Apr 2024
Confirmation statement made on 18 September 2023 with no updates
Submitted on 28 Sep 2023
Register inspection address has been changed from 2 Temple Back East Temple Quay Bristol BS1 6EG England to 5th Floor Halo Counterslip Bristol BS1 6AJ
Submitted on 21 Jul 2023
Register(s) moved to registered inspection location 2 Temple Back East Temple Quay Bristol BS1 6EG
Submitted on 20 Jul 2023
Total exemption full accounts made up to 31 December 2022
Submitted on 28 Mar 2023
Confirmation statement made on 18 September 2022 with no updates
Submitted on 28 Sep 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year